• Home
  • Top Stories
  • Markets
  • Market Data
  • Companies
  • Opinion
  • Economy & Policy
  • Finance
  • Politics
  • Technology
  • Personal Finance
  • Current Affairs
  • International
  • Management
  • Weekend
  • General News
  • Latest News
  • Today's Paper
  • Videos
  • Covid-19
  • Portfolio
  • Login

Glaxosmithkline Pharmaceuticals
Drugmakers to hike prices for 2021 as Covid pressure puts revenues at risk
GlaxoSmithKline Pharma Q2 net profit declines 85% to Rs 76.47 crore
Sanofi, GSK to supply up to 60 million doses of Covid-19 vaccine to UK
Sanofi eyes Covid-19 vaccine approval in early 2021; partners Translate Bio
GlaxoSmithKline Q4 consolidated net profit declines 6% to Rs 138 cr

PPEs, work-life balance the new normal as pharma salesforce hits the field
GSK to offload HUL stake worth Rs 26,000 cr in largest secondary sale
GlaxoSmithKline Pharma plunges 13% on net loss of Rs 661 crore in Q3
GSK credits STEER for Horlicks technology after year-long IP battle
From Celin to Septran, GSK Pharma sold 8-10 tail-end brands in FY19

GlaxoSmithKline, Pfizer to combine consumer health businesses in JV
GSK Pharma to pare brands to 20 in India, bring new products into country
GlaxoSmithKline Pharmaceuticals zooms 17% on 1:1 bonus
Cloud over GlaxoSmithKline deal affects outlook; stock down by 8.3%
GSK in pole position for Pfizer unit as Reckitt Benckiser quits auction
GlaxoSmithKline, Reckitt Benckiser in final lap for Pfizer Inc's unit
GlaxoSmithKline sets up first team for acquisitions in 93 years
GSK hires ex-Walmart executive to boost tech operations, digital platforms
GSK puts old antibiotics and UK Horlicks biz on the block
GlaxoSmithKline Pharma Q3 profit dips 33 per cent at Rs 53 crore
Next 
⇧ Back to Top
  • Top Stories
  • Markets
  • Market Data
  • Companies
  • Opinion
  • Economy & Policy
  • Finance
  • Politics
  • Technology
  • Personal Finance
  • Current Affairs
  • International
  • Budget 2021
  • Insurance Round Table 2020
View Full Site >>
Copyrights © 2021 Business Standard Private Ltd. All rights reserved